Anna P Andreou
Anna P Andreou
Primary Investigator, Headache Research, Imperial College London
Verified email at imperial.ac.uk
Title
Cited by
Cited by
Year
Neurobiology of migraine
PJ Goadsby, AR Charbit, AP Andreou, S Akerman, PR Holland
Neuroscience 161 (2), 327-341, 2009
3862009
Assessing the risk of central post-stroke pain of thalamic origin by lesion mapping
T Sprenger, CL Seifert, M Valet, AP Andreou, A Foerschler, C Zimmer, ...
Brain 135 (8), 2536-2545, 2012
1032012
Acid‐sensing ion channel 1: A novel therapeutic target for migraine with aura
PR Holland, S Akerman, AP Andreou, N Karsan, JA Wemmie, ...
Annals of neurology 72 (4), 559-563, 2012
922012
Modulation of nocioceptive transmission with calcitonin gene-related peptide receptor antagonists in the thalamus
O Summ, AR Charbit, AP Andreou, PJ Goadsby
Brain 133 (9), 2540-2548, 2010
872010
Transcranial magnetic stimulation and potential cortical and trigeminothalamic mechanisms in migraine
AP Andreou, PR Holland, S Akerman, O Summ, J Fredrick, PJ Goadsby
Brain 139 (7), 2002-2014, 2016
852016
Transient receptor potential ion channels in primary sensory neurons as targets for novel analgesics
J Sousa‐Valente, AP Andreou, L Urban, I Nagy
British journal of pharmacology 171 (10), 2508-2527, 2014
822014
Therapeutic potential of novel glutamate receptor antagonists in migraine
AP Andreou, PJ Goadsby
Expert opinion on investigational drugs 18 (6), 789-803, 2009
792009
Animal models of headache: from bedside to bench and back to bedside
AP Andreou, O Summ, AR Charbit, M Romero-Reyes, PJ Goadsby
Expert review of neurotherapeutics 10 (3), 389-411, 2010
702010
Pharmacology of the capsaicin receptor, transient receptor potential vanilloid type-1 ion channel
I Nagy, D Friston, JS Valente, JVT Perez, AP Andreou
Capsaicin as a Therapeutic Molecule, 39-76, 2014
672014
Evidence for orexinergic mechanisms in migraine
J Hoffmann, W Supronsinchai, S Akerman, AP Andreou, CJ Winrow, ...
Neurobiology of disease 74, 137-143, 2015
652015
Topiramate in the treatment of migraine: a kainate (glutamate) receptor antagonist within the trigeminothalamic pathway
AP Andreou, PJ Goadsby
Cephalalgia 31 (13), 1343-1358, 2011
642011
A potential nitrergic mechanism of action for indomethacin, but not of other COX inhibitors: relevance to indomethacin-sensitive headaches
O Summ, AP Andreou, S Akerman, PJ Goadsby
The journal of headache and pain 11 (6), 477-483, 2010
642010
GABA and valproate modulate trigeminovascular nociceptive transmission in the thalamus
AP Andreou, KG Shields, PJ Goadsby
Neurobiology of disease 37 (2), 314-323, 2010
612010
Primary headaches during lifespan
A Straube, A Andreou
The journal of headache and pain 20 (1), 1-14, 2019
492019
Mechanisms of migraine as a chronic evolutive condition
AP Andreou, L Edvinsson
The journal of headache and pain 20 (1), 1-17, 2019
482019
Prevalence of migraine headache and its weight on neurological burden in Africa: a 43-year systematic review and meta-analysis of community-based studies
YW Woldeamanuel, AP Andreou, RP Cowan
Journal of the neurological sciences 342 (1-2), 1-15, 2014
462014
A prospective real-world analysis of erenumab in refractory chronic migraine
G Lambru, B Hill, M Murphy, I Tylova, AP Andreou
The Journal of Headache and Pain 21, 1-10, 2020
412020
Activation of iGluR5 kainate receptors inhibits neurogenic dural vasodilatation in an animal model of trigeminovascular activation
AP Andreou, PR Holland, PJ Goadsby
British journal of pharmacology 157 (3), 464-473, 2009
402009
Emerging drugs for migraine treatment: an update
G Lambru, AP Andreou, M Guglielmetti, P Martelletti
Expert opinion on emerging drugs 23 (4), 301-318, 2018
392018
Immunohistochemical characterization of calcitonin gene-related peptide in the trigeminal system of the familial hemiplegic migraine 1 knock-in mouse
R Mathew, AP Andreou, L Chami, A Bergerot, ...
Cephalalgia 31 (13), 1368-1380, 2011
342011
The system can't perform the operation now. Try again later.
Articles 1–20